No evidence that COVID 19 vaccines affect women's periods

200
3
No evidence that COVID 19 vaccines affect women's periods

Nov 15, Reuters - The following is a summary of some recent studies on COVID 19. They have research that warrants further studies to corroborate the findings and has yet to be certified by peer review.

There is no link between vaccine and menstrual changes.

Many women have reported noticing changes in their menstrual cycle after having been vaccinated against COVID 19 but a new study of 1,273 women in the UK found no correlation, according to a report posted on Monday on medRxiv ahead of peer review https: www.medrxiv. The women in the study kept a record of their cycles and their vaccination dates. Victoria Male from Imperial College London said that we were not able to detect strong signals to support the idea that COVID 19 vaccines are linked to changes in timing or flow of women's periods. She said that it is possible that larger studies, or studies in other countries, might find links. It is important to note that most people who report such a change after vaccination find that their period returns to normal the following cycle. Male added that there was no evidence that the vaccines affect female fertility.

You can get COVID 19 vaccine, flu shot together.

According to a report published on Thursday, it is safe to administer COVID 19 vaccines and flu vaccines to patients at the same time, and may increase vaccination rates. The researchers randomly assigned 697 adult volunteers to receive their second dose of either the mRNA vaccine from Pfizer BioNTech or the viral-vector vaccine from AstraZeneca Oxford, along with one of three influenza vaccines for the 2020 -- 2021 season FluAd or Flucelvax from Seqirus UK or Flublok from Sanofi or a placebo. The study found that most of the shots were mild or moderate, and antibody responses to the vaccines were not adversely affected by getting two shots at once. The research team concluded that giving both vaccines at a single appointment will reduce the burden on health-care services for vaccine delivery, allowing for timely vaccine administration and protection from COVID 19 and influenza for those in need.

Even though treatment that suppresses the immune system, a small study suggests that lung cancer patients may get good protection from mRNA COVID 19 vaccines. Between January and July this year, researchers in France administered the vaccine from Pfizer BioNTech to 306 lung cancer patients, 70% of whom had recently received immunosuppressive therapies that impair the ability to respond to vaccines. Patients with COVID 19 antibodies from a previous infection received only one dose, but most patients received both doses, according to a paper released on Monday. It is scheduled to be published in the Journal of Thoracic Oncology at: bit.ly 3 kEkxKH. About 10% of the patients failed to develop antibodies in response to the first two doses and received a third dose, which successfully induced antibodies in all but three individuals with blood disorders that have been known to affect the effect of the vaccines. The death rate for lung cancer patients who developed COVID-19 was 30% before vaccines, according to the researchers. In this seven-month study, only eight patients, or 2.6% of the total, developed mild cases of COVID - 19. The investigators called for more research to confirm their findings because the study was small and not randomized.